[Home ] [Archive]    
:: Main About journal Editorial Board Current Issue Archive Submit an article Site Map Contact ::
Main Menu
Home::
Journal Information::
Articles archive::
For Authors::
For Reviewers::
Registration::
Contact us::
Site Facilities::
Editorial Board::
::
Search in website

Advanced Search
..
Receive site information
Enter your Email in the following box to receive the site news and information.
..
:: Volume 3, Issue 2 (June 2014) ::
Int J Med Invest 2014, 3(2): 0-0 Back to browse issues page
IMPACT OF GENETIC POLYMORPHISM OF ABCB1 (MDR1) 2677G>T –A IN KIDNEY DONORS ON TACROLIMUS LEVEL IN JORDANIAN KIDNEY TRANSPLANT RECIPIENTS DURING THE EARLY POST TRANSPLANTATION PERIOD
Ahmad Masadeh * , Nailya Bulatova , Al-Motassem Yousef , Tareq Abu-Al ganam
King Hussein Medical Centre, Royal Medical Services, Amman, Jordan
Abstract:   (8725 Views)
The aim of this study was to determine the role of donors’ ABCB1 G2677T/A polymorphism on tacrolimus dose requirements, trough levels and dose-adjusted trough concentrations among Jordanian renal transplant recipients during the early, unstable period post transplantation.Donors of those renal transplant recipients who were started on tacrolimus post-transplantation (n=53) were genotyped for MDR1 G2677T/A using Polymerase Chain Reaction-Restriction Fragment Length Polymorphism (PCR-RFLP) analysis. Tacrolimus doses (mg/kg body weight), trough concentrations (ng/ml), dose-adjusted trough concentrations (ng/ml per mg/kg body weight) were compared among patients according to donors’ allelic status for MDR1 (G2677T/A). Among the 53 donors, 28 (52.8%) were carriers of GG, 20 (37.7%) of GT, and 5 (9.4%) of TT MDR1 alleles. Trough tacrolimus concentrations in recipients of donors carrying at least one T mutant alleles (2677TT or 2677GT, serine phenotype) did not differ significantly from trough concentration in recipients of donors carrying homozygote wild, 2677GG genotype (alanine) during the early 6 months post renal transplantation (P = 0.40, 0.62, 0.42, 0.60, 0.93, 0.66 for months 1-6, respectively). In conclusion, donor’s MDR1 gene polymorphism has no impact on trough tacrolimus concentration during the early period post-transplantation. To date, the results of studies remain controversial and many other factors must be considered to predict variability profile of trough tacrolimus levels accurately.
Keywords: Tacrolimus, dose requirements, trough levels, dose-adjusted trough concentrations
Full-Text [PDF 610 kb]   (1736 Downloads)    
Type of Study: Research | Subject: General
Add your comments about this article
Your username or Email:

CAPTCHA


XML     Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Ahmad Masadeh, Nailya Bulatova, Al-Motassem Yousef, Tareq Abu-Al ganam. IMPACT OF GENETIC POLYMORPHISM OF ABCB1 (MDR1) 2677G>T –A IN KIDNEY DONORS ON TACROLIMUS LEVEL IN JORDANIAN KIDNEY TRANSPLANT RECIPIENTS DURING THE EARLY POST TRANSPLANTATION PERIOD. Int J Med Invest 2014; 3 (2)
URL: http://intjmi.com/article-1-64-en.html


Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Volume 3, Issue 2 (June 2014) Back to browse issues page
International Journal of Medical Investigation
Persian site map - English site map - Created in 0.05 seconds with 37 queries by YEKTAWEB 4645